BDXB — Becton Dickinson and Co Share News
0.000.00%
Last trade - 00:00- $71.51bn
- $87.75bn
- $18.87bn
Brief: Becton Dickinson and Co Launches Next Generation Prefillable Vaccine Syringe Designed For Reliability, Efficiency
NYSE ORDER IMBALANCE 64954.0 SHARES ON BUY SIDE
Brief: Becton Dickinson and Co Issued $500 Million Aggregate Principal Amount Of 4.298% Notes Due August 22, 2032 In An Underwritten Public Offering
Accelerate Diagnostics slides 14% on stock offering
Brief: Accelerate Diagnostics Appoints Becton, Dickinson And Co As Its Worldwide Exclusive Sales Agent
Accelerate Diagnostics rises on partnership with Becton Dickinson
Brief: BD, Accelerate Diagnostics Announce Global Commercial Collaboration
Brief: BD, Labcorp Collaborate To Develop Flow Cytometry-Based Companion Diagnostics For Matching Patients With Treatments
Brief: Bd - Files Pricing Term Sheet For $500 Million Offering Of 4.298% Notes Due 2032
Brief: BD Files Prospectus Related To Senior Notes Offering Size Not Disclosed - SEC Filing
Brief: BD Announces Tender Offers For Outstanding Debt Securities
U.S. STOCKS ON THE MOVE-U.S. homebuilders, AMC Entertainment
U.S. STOCKS ON THE MOVE-Nikola, Coinbase, BridgeBio
Becton Dickinson up on 2022 profit forecast raise
Brief: BD Reports Q3 Adjusted Earnings Per Share $2.66
NYSE ORDER IMBALANCE 71203.0 SHARES ON BUY SIDE
Brief: BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software
Brief: Becton Dickinson, Certest Biotec Announce Commercial Launch Of Monkeypox Test
NYSE ORDER IMBALANCE 54909.0 SHARES ON BUY SIDE